ArticleFrontiers in immunology2022

PDK4 Inhibition Ameliorates Melatonin Therapy by Modulating Cerebral Metabolism and Remyelination in an EAE Demyelinating Mouse Model of Multiple Sclerosis.

Majid Ghareghani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.